AGP Executive Report
Last update: 7 hours agoAbortion Rights in Focus (Liechtenstein): A new push to modernise Liechtenstein’s very strict abortion rules is again colliding with the royal veto power, with reporting pointing to Hereditary Prince Alois as the key obstacle to legal change. Cancer Care Deal (Liechtenstein-linked): IMPACT Therapeutics and Pharmanovia signed an exclusive licensing agreement for senaparib, aiming to expand access across 66 countries, including Liechtenstein, with payments potentially reaching €423.5m. Public Health Research (Hepatitis B): European experts highlight the gap between a long-available hepatitis B vaccine and the lack of a cure for people already living with chronic infection, noting millions affected across the EU plus Liechtenstein and Norway. Food Safety at Borders (Liechtenstein travellers): UK guidance warns travellers returning from EU countries, including Liechtenstein, that bringing back meat and dairy is restricted and can trigger fines or prosecution. Healthcare Data Breach (US): Brown Health Medical Group-MA says a breach exposed sensitive personal and medical data for 311,000 people.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
